Loading ...
Method and apparatusto preventstent
E.g. Palmazinventedstent
specifically for the treatment of recurrent strictures along the bulbar urethra(passive) is designedBulbar Stent
to provide high flexibility in reaching areas characterized by tortuous lesion(passive) is designedStent
Bent stents were usedto preventstent displa
with small distinctive interconnectors , which is implanted in the(passive) is designedStentyss stent
to impart an outward radial force upon the inner lumen of the vessel , establishing patency in the stented region(passive) is designedstent
Although drug - eluting stents ( DES ) significantly reduce restenosis , they require 3 to 6 months of thienopyridine therapyto preventstent
over - expansion of the stents beyond the maximum design diameter(passive) caused bystent
The CATANIA(TMcreatesstent
expanding the stents beyond their maximum design diameter(passive) caused bystent
coronary arteries stent / polymer / drug eluting Siro ™ Features : The Siro ™ drug elutingsetsstent
novel designs and materials customized for particular lesion types and newer anti - restenotic treatmentscould influencestent thrombogenicity
The implantation ofpreventsstent
to match the restenotic cascade for better healing and patency in the superficial femoral arteries ( SFA(passive) was designedStent
The outer tubular member orpreventsstent
critical factorsinfluencingstent thrombogenicity
in 1988(passive) was inventedMonoka stent
a drug or a condition(passive) caused bystent
Manifold and stopcock IntroducersetsCatheterization stent
REVA Medical(passive) designed bystent
to Provide Early Healing(passive) was DesignedStent
two blood - thinning medicationsPRESTIGE study suggests novel targetto preventstent
guiding catheter or other interventional devices ( Online Figure S3(passive) caused bystent
to provide outstanding scaffolding and support to the vessel and features high radial force and longitudinal stability(passive) is designedStent
for the treatment of coronary artery disease in a broad range of patients , not just those with easy - to - treat lesions(passive) was designedStent
to help the tissue ingrowth through the implantedTo preventstent
A current development ... a thin layer of synthetic materialshould preventstent reocclusion
novel focus onto preventstent
to deliver controlled , localized , low - dose amorphous paclitaxel to target lesions(passive) is designedStent
percutaneous coronary intervention ( PCI ) with stent insertionto preventstent
dual antiplatelet therapy ... stent insertionto preventstent
specially(passive) was ... designedstent
Atala 's team will helppreventstent
to address these concerns(passive) is designedVenovo stent
The goal was uniquelyto preventstent
Dissolvable or degradable adhesive polymerto preventstent
Max Delbruck , who won the Nobel Prize in Physiology or Medicine in 1969 for his work demonstrating that linkurl(passive) was greatly influenced byStent
50 ° flexion for plastic stent is recommendedto preventstent migration.19
the present invention(passive) created bystent
for the delivery of therapeutic substance or other agents Next Patentdesignedfor the delivery of therapeutic substance or other agents Next Patent
for the delivery of therapeutic substance or other agentsUS83489949 Mar 20078designedfor the delivery of therapeutic substance or other agentsUS83489949 Mar 20078
for the delivery of therapeautic substance or other agentsdesignedfor the delivery of therapeautic substance or other agents
for the delivery of therapeutic substance or other agentsUS701486124 oktdesignedfor the delivery of therapeutic substance or other agentsUS701486124 okt
for the delivery of therapeutic substance or other agentsUS704896230 juildesignedfor the delivery of therapeutic substance or other agentsUS704896230 juil
for the delivery of therapeutic substance or other agentsUS830911224 Dicdesignedfor the delivery of therapeutic substance or other agentsUS830911224 Dic
for the delivery of therapeutic substance or other agentsUS830364824 avrdesignedfor the delivery of therapeutic substance or other agentsUS830364824 avr
for the delivery of therapeautic substance or other agentsWO2003049640A22 d � cdesignedfor the delivery of therapeautic substance or other agentsWO2003049640A22 d � c
for the delivery of therapeutic substance or other agentsUS70294923 Mar 200018designedfor the delivery of therapeutic substance or other agentsUS70294923 Mar 200018
for the delivery of therapeutic substance or other agentsUS701840513 Feb 200128designedfor the delivery of therapeutic substance or other agentsUS701840513 Feb 200128
for the delivery of therapeutic substance or other agentsUS704896230 Jul 200223designedfor the delivery of therapeutic substance or other agentsUS704896230 Jul 200223
for the delivery of therapeutic substance or other agentsUS830364223 maj 20036designedfor the delivery of therapeutic substance or other agentsUS830364223 maj 20036
for the delivery of therapeutic substance or other agentsUS830364223 mai 20036designedfor the delivery of therapeutic substance or other agentsUS830364223 mai 20036
for the delivery of therapeutic substance or other agentsUS829856514 Jul 200630designedfor the delivery of therapeutic substance or other agentsUS829856514 Jul 200630
for the delivery of therapeutic substance or other agentsUS704496513 Dic 200216designedfor the delivery of therapeutic substance or other agentsUS704496513 Dic 200216
for the delivery of therapeutic substance or other agentsUS836114029 Dic 201029designedfor the delivery of therapeutic substance or other agentsUS836114029 Dic 201029
for the delivery of therapeutic substance or other agentsUS829827712 Nov 200930designedfor the delivery of therapeutic substance or other agentsUS829827712 Nov 200930
for the delivery of therapeutic substance or other agentsUS830911224 Dec 200313designedfor the delivery of therapeutic substance or other agentsUS830911224 Dec 200313
for the delivery of therapeutic substance or other agentsUS830952119 Jun 200713designedfor the delivery of therapeutic substance or other agentsUS830952119 Jun 200713
for the delivery of therapeutic substance or other agentsUS83044512 mai 20076designedfor the delivery of therapeutic substance or other agentsUS83044512 mai 20076
for the delivery of therapeutic substance or other agentsUS7055237Sep 29 , 2003Jun 6designedfor the delivery of therapeutic substance or other agentsUS7055237Sep 29 , 2003Jun 6
for the delivery of therapeutic substance or other agentsUS8303609Sep 28 , 2001Nov 6designedfor the delivery of therapeutic substance or other agentsUS8303609Sep 28 , 2001Nov 6
for the delivery of therapeutic substance or other agentsUS8328863Apr 22 , 2010Dec 11designedfor the delivery of therapeutic substance or other agentsUS8328863Apr 22 , 2010Dec 11
for the delivery of therapeutic substance or other agentsUS20060008503Sep 13 , 2005Jan 12designedfor the delivery of therapeutic substance or other agentsUS20060008503Sep 13 , 2005Jan 12
for the delivery of therapeutic substance or other agentsUS8304451May 2 , 2007Nov 6designedfor the delivery of therapeutic substance or other agentsUS8304451May 2 , 2007Nov 6
for the delivery of therapeutic substance or other agentsUS8317851Mar 31 , 2006Nov 27 , 2012Medinol Ltddesignedfor the delivery of therapeutic substance or other agentsUS8317851Mar 31 , 2006Nov 27 , 2012Medinol Ltd
for the delivery of therapeutic substance or other agentsUS702237212 nov . 20024 avrdesignedfor the delivery of therapeutic substance or other agentsUS702237212 nov . 20024 avr
for the delivery of therapeutic substance or other agentsUS70183717designedfor the delivery of therapeutic substance or other agentsUS70183717
for the delivery of therapeutic substance or other agentsUS7169177designedfor the delivery of therapeutic substance or other agentsUS7169177
for the delivery of therapeutic substance or other agentsUS7105175designedfor the delivery of therapeutic substance or other agentsUS7105175
for the delivery of therapeutic substance or other agentsUS7055237designedfor the delivery of therapeutic substance or other agentsUS7055237
for the delivery of therapeutic substance or other agentsUS7128862designedfor the delivery of therapeutic substance or other agentsUS7128862
for the delivery of therapeutic substance or other agentsUS7029492designedfor the delivery of therapeutic substance or other agentsUS7029492
for the delivery of therapeutic substance or other agentsUS7175644designedfor the delivery of therapeutic substance or other agentsUS7175644
for the delivery of therapeutic substance or other agentsUS20010027339designedfor the delivery of therapeutic substance or other agentsUS20010027339
for the delivery of therapeutic substance or other agentsUS7029488designedfor the delivery of therapeutic substance or other agentsUS7029488
for the delivery of therapeutic substance or other agentsUS20050287287designedfor the delivery of therapeutic substance or other agentsUS20050287287
for the delivery of therapeutic substance or other agentsUS20050283227designedfor the delivery of therapeutic substance or other agentsUS20050283227
for the delivery of therapeutic substance or other agentsUS7044965designedfor the delivery of therapeutic substance or other agentsUS7044965
for the delivery of therapeutic substance or other agentsUS20060058743designedfor the delivery of therapeutic substance or other agentsUS20060058743